Please login to the form below

Not currently logged in
Email:
Password:

Alector

This page shows the latest Alector news and features for those working in and with pharma, biotech and healthcare.

Biogen and Eisai pull plug on Alzheimer’s drug

Biogen and Eisai pull plug on Alzheimer’s drug

One example is US biotech Alector, whose lead candidate AL002 targets a triggering receptor expressed on myeloid cells 2 (TREM2) and is based on a view that the disease is caused

Latest news

  • Alector kicks off next wave of biotech IPOs Alector kicks off next wave of biotech IPOs

    Alector is pioneering immuno-neurology, a novel therapeutic that will treat a range of degenerative brain disorders by restoring healthy immune function to the brain. ... Hot on Alector’s heels is Stealth BioTherapeutics, which is aiming to raise $81

  • J&J and Bayer unveil new bioincubators J&J and Bayer unveil new bioincubators

    Places in J&J's bioincubators have already yielded funding and licensing deals for the likes of Alector, Bell Biosystems and Araxes Pharma.

  • J&J adds Manchester to partnering network J&J adds Manchester to partnering network

    Alector is targeting key components of the pathological pathways that underlie Alzheimer's using monoclonal antibody technology via its strategic alliance with antibody discovery specialist Adimab. ... This agreement provides Alector with a lot of

More from news
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Brain power: fresh approaches to Alzheimer’s drug discovery Brain power: fresh approaches to Alzheimer’s drug discovery

    Angus Grant, CEO of the Dementia Discovery Fund, said: “I am delighted that Alector, the first of DDF’s investments, has reached this significant milestone. ... Alector’s progress serves as a great illustration of how the DDF’s investment choices

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics